Preclinical, Translational and Clinical-Stage Laboratories
Who We Are
MD Biosciences is a global industry-leading provider of preclinical, translational and clinical-phase contract research services for the development of pharmaceutical and diagnostic assets. With AAALAC-accredited, GLP-compliant, CLIA facilities, we offer services and products across a wide range of therapeutic areas including inflammatory diseases, autoimmunity, neurology, oncology, metabolism and pain. In order to provide the best quality offerings with expertise and optimize research in each specialized area, we operate 4 separate divisions: MD Biosciences Inflammation/Immunology Services, MD Biosciences Neurology Discovery Services, MD Biosciences Histopathology Services and MD Bioproducts.
What We Do
Advanced capabilities for in-depth assessment of tissue parameters with support at each stage in the histology workflow including digital image analysis. From sample preparation through to staining and assessment by our pathologists, we ensure the highest quality of data production to progress your programs forward. We have developed histological assays, IHC protocols, custom ISH probes and unique scoring methods for numerous project types with standard and customized read outs, and are always willing to discuss new assessments to meet client needs.